Tirilazad
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Tirilazad is a drug proposed to treat acute ischaemic stroke, however results are mixed as to whether the drug truly treats stroke.[1]
Mixed results
Mixed results
When tested on animal models, tirilazad protects brain tissue, and reduces any brain damage. On the contrary, the drug fails to treat, and even worsens a stroke when studied on a human being.
Usage in treatment of stroke
Usage in treatment of stroke
Tirilazad currently has no usage in the clinical treatment of stroke.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH